NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science
Key Details
Context & Analysis
National Institutes of Health posted this funding opportunity on September 10, 2026 (opportunity number RFA-DA-28-002). It is catalogued under CFDA number 93.279.
Similar Grant Opportunities
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)
National Institutes of Health
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
National Institutes of Health
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
National Institutes of Health
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
National Institutes of Health
Stay Updated
Get notified about new opportunities matching your interests.